mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.4 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |